BIOMAT Database Logo BIOMAT Database Logo

Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. 1986

R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick

UI MeSH Term Description Entries
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000262 Adenylyl Cyclases Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP. Adenyl Cyclase,Adenylate Cyclase,3',5'-cyclic AMP Synthetase,Adenylyl Cyclase,3',5' cyclic AMP Synthetase,AMP Synthetase, 3',5'-cyclic,Cyclase, Adenyl,Cyclase, Adenylate,Cyclase, Adenylyl,Cyclases, Adenylyl,Synthetase, 3',5'-cyclic AMP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D017447 Receptors, Dopamine D1 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES. Dopamine D1 Receptors,Dopamine-D1 Receptor,D1 Receptors, Dopamine,Dopamine D1 Receptor,Receptor, Dopamine-D1

Related Publications

R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Multiple forms of adenylate cyclase.
January 1978, Advances in cyclic nucleotide research,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
October 2005, Molecular pharmacology,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.
February 1996, Biochemical Society transactions,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Irradiation inactivation studies of the dopamine D1 receptor and dopamine-stimulated adenylate cyclase in rat striatum.
December 1987, Neuroscience letters,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
August 1991, British journal of pharmacology,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Is adenylate cyclase the dopamine receptor?
October 1974, Medical biology,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".
August 1972, Proceedings of the National Academy of Sciences of the United States of America,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum.
February 1997, Neuroscience letters,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
The influence of cholesterol on synaptic fluidity, dopamine D1 binding and dopamine-stimulated adenylate cyclase.
January 1989, Brain research bulletin,
R B Mailman, and D W Schulz, and C D Kilts, and M H Lewis, and H Rollema, and S Wyrick
Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
December 1986, Journal of neurochemistry,
Copied contents to your clipboard!